S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ENLV Enlivex Therapeutics Ltd

1.12

-0.03 (-2.61%)

After Hours

Last Updated: 09:46:45

Delayed by 15 minutes

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Enlivex Therapeutics (NASDAQ:ENLV)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Enlivex Therapeutics Charts.

Enlivex Therapeutics (NASDAQ:ENLV)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Enlivex Therapeutics Charts.

Enlivex Therapeutics Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
Thursday 12 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 4 December 2024 (2 months ago) • Edgar (US Regulatory)

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis
Wednesday 4 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 30 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Enlivex Adopts Bitcoin Treasury Reserve Strategy
Thursday 21 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis
Friday 15 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Enlivex Announces the Enrollment and Dosing of the First 10 Patient in the Randomized Phase II Stage of its Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

More Enlivex Therapeutics Ltd News Articles

Solaris Resources

Xtrackers Msci Russia Ca...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions